Neurology News

SEATTLE — Subtypes of seizures have improved through the use of cenobamate, William E. Rosenfeld, MD, FAAN, said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Higher frequency of seizures and relatively poor quality of life are significant risk factors for depression in patients with epilepsy, according to a presentation at the 2022 American Academy of Neurology annual meeting.

WASHINGTON — Compared with regular salt intake, using a salt substitute was associated with better outcomes at lower cost for stroke prevention and quality-adjusted life-years gained, according to new data from the SSaSS trial.

The presence of newborn neurons and an immature version of a related cell, known as astroglia, were found in patients with epilepsy, researchers reported in Nature Neuroscience.

SEATTLE — A decrease in the severity of tics in children and adolescents with Tourette syndrome was observed following the use of ecopipam, according to data presented at the 2022 American Academy of Neurology annual meeting.

CMS announced that Medicare is limiting coverage of the controversial Alzheimer’s disease drug Aduhelm to participants who are enrolled in FDA- or NIH-approved clinical trials.

SEATTLE — Abnormalities during sleep may be associated with neurological conditions, Alberto Ramos, MD, a sleep disorder specialist at the University of Miami, said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Fatigue is a frequent concern for patients with MS in the United Kingdom and has multiple predictors, according to a presenter at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Although successful tau therapeutics have not yet been identified, new insights into the protein’s biology may soon lead to treatments, according to a presenter at the 2022 American Academy of Neurology annual meeting.

SEATTLE — The use of 30 mg per day of zolpidem may significantly improve quality of life among patients with prolonged disorders of consciousness, a presenter said at the 2022 American Academy of Neurology annual meeting.